A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease

Neurobiology of Aging

Volumn 33, Issue 3, 2012, Pages 624.e11-624.e22

  Saresella, Marina ^a   Calabrese, Elena ^a   Marventano, Ivana ^a   Piancone, Federica ^a   Gatti, Andrea ^a   Farina, Elisabetta ^a   Alberoni, Margherita ^a   Clerici, Mario ^a,b  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; Apoptosis; Immunology; Inflammation; Interleukin 10; PD L1; PD1

Indexed keywords

AMYLOID BETA PROTEIN; CD14 ANTIGEN; INTERLEUKIN 10; LIPOCORTIN 5; MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY; PROGRAMMED DEATH 1; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 1 NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 84855798691     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.03.004     Document Type: Article

References (52)

1. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-R 1994, American Psychiatric Association.
2. Arosio B., Trabattoni D., Galimberti L., Bucciarelli P., Fasano F., Calabresi C., Cazzullo C.L., Vergani C., Annoni G., Clerici M. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol. Aging 2004, 25:1009-1015.
3. Bharadwaj P.R., Dubey A.K., Masters C.L., Martins R.N., Macreadie I.G. Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. J. Cell. Mol. Med 2009, 13:412-421.
4. Blank C., Brown I., Marks R., Nishimura H., Honjo T., Gajewski T.F. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells. J. Immunol 2003, 171:4574-4581.
5. Castle S.C., Uyemura K., Crawford W., Wong W., Klaustermeyer W.B., Makinodan T. Age-related impaired proliferation of peripheral blood mononuclear cells is associated with an increase in both IL-10 and IL-12. Exp. Gerontol 1999, 34:243-252.
6. Dong H., Chen L. B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med 2003, 81:281-287.
7. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K., Lennon V.A., Celis E., Chen L. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med 2002, 8:793-800.
8. Dong H., Zhu G., Tamada K., Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med 1999, 5:1365-1369.
9. Finder V.H., Glockshuber R. Amyloid-beta aggregation. Neurodegener Dis 2007, 4:13-27.
10. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
11. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., Horton H.F., Fouser L., Carter L., Ling V., Bowman M.R., Carreno B.M., Collins M., Wood C.R., Honjo T. Engagement of the PD1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med 2000, 192:1027-1034.
12. Guleria I., Khosroshahi A., Ansari M.J., Habicht A., Azuma M., Yagita H., Noelle R.J., Coyle A., Mellor A.L., Khoury S.J., Sayegh M.H. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med 2005, 202:231-237.
13. Holets L.M., Hunt J.S., Petroff M.G. Trophoblast CD274 (B7-H1) is differentially expressed across gestation: influence of oxygen concentration. Biol. Reprod 2006, 74:352-358.
14. Hori J., Wang M., Miyashita M., Tanemoto K., Takahashi H., Takemori T., Okumura K., Yagita H., Azuma M. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol 2006, 177:5928-5935.
15. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br J Psychiatry 1982, 140:566-572.
16. Ke Z.J., Bowen W.M., Gibson G.E. Peripheral inflammatory mechanisms modulate microglial activation in response to mild impairment of oxidative metabolism. Neurochem. Int 2006, 49:548-556.
17. Keir M.E., Francisco L.M., Sharpe A.H. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol 2007, 19:309-314.
18. Keir M.E., Latchman Y.E., Freeman G.J., Sharpe A.H. Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes. J. Immunol 2005, 175:7372-7379.
19. Koronyo-Hamaoui M., Ko M.K., Koronyo Y., Azoulay D., Seksenyan A., Kunis G., Pham M., Bakhsheshian J., Rogeri P., Black K.L., Farkas D.L., Schwartz M. Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J. Neurochem 2009, 111:1409-1424.
20. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., Greenfield E.A., Bourque K., Boussiotis V.A., Carter L.L., Carreno B.M., Malenkovich N., Nishimura H., Okazaki T., Honjo T., Sharpe A.H., Freeman G.J. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol 2001, 2:261-268.
21. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., Sharpe A.H. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol 2003, 33:2706-2716.
22. Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., Müller-Hermelink H.K., Steinmann G.G. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing Dev 1984, 28:47-55.
23. Lio D., Scola L., Crivello A., Colonna-Romano G., Candore G., Bonafè M., Cavallone L., Franceschi C., Caruso C. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun 2002, 3:30-33.
24. Lombardi V.R., García M., Rey L., Cacabelos R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals. J. Neuroimmunol 1999, 97:163-171.
25. Ma S.L., Tang N.L., Lam L.C., Chiu H.F. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiol. Aging 2005, 26:1005-1010.
26. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
27. Meng Q., Yang P., Li B., Zhou H., Huang X., Zhu L., Ren Y., Kijlstra A. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation. Invest. Ophthalmol. Vis. Sci 2006, 47:4444-4452.
28. Parry R.V., Chemnitz J.M., Frauwirth K.A., Lanfranco A.R., Braunstein I., Kobayashi S.V., Linsley P.S., Thompson C.B., Riley J.L. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol 2005, 25:9543-9553.
29. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med 2004, 256:183-194.
30. Petrovas C., Casazza J.P., Brenchley J.M., Price D.A., Gostick E., Adams W.C., Precopio M.L., Schacker T., Roederer M., Douek D.C., Koup R.A. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J. Exp. Med 2006, 203:2281-2292.
31. Qian L., Hong J.S., Flood P.M. Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10. J. Neural Transm. Suppl 2006, 70:367-371.
32. Riley J.L. PD-1 signaling in primary T cells. Immunol. Rev 2009, 229:114-125.
33. Saresella M., Marventano I., Guerini F.R., Zanzottera M., Delbue S., Marchioni E., Maserati R., Longhi R., Ferrante P., Clerici M. Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases. Clin. Immunol 2008, 129:509-517.
34. + T Regulatory Cells in Mild Cognitive Impairment and Alzheimer's Disease. J. Alzheimers Dis 2010, 21:927-938.
35. Selenko-Gebauer N., Majdic O., Szekeres A., Höfler G., Guthann E., Korthäuer U., Zlabinger G., Steinberger P., Pickl W.F., Stockinger H., Knapp W., Stöckl J. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol 2003, 170:3637-3644.
36. Sharpe A.H., Wherry E.J., Ahmed R., Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol 2007, 8:239-245.
37. Speciale L., Calabrese E., Saresella M., Tinelli C., Mariani C., Sanvito L., Longhi R., Ferrante P. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol. Aging 2007, 28:1163-1169.
38. Schwartz M., Shechter R. Systemic inflammatory cells fight off neurodegenerative disease. Nat. Rev. Neurol 2010, 6:405-410.
39. Tan J., Town T., Mullan M. CD40-CD40L interaction in Alzheimer's disease. Curr Opin Pharmacol 2002, 2:445-451.
40. Tan J., Town T., Paris D., Mori T., Suo Z., Crawford F., Mattson M.P., Flavell R.A., Mullan M. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 1999, 286:2352-2355. a.
41. Tan J., Town T., Suo Z., Wu Y., Song S., Kundtz A., Kroeger J., Humphrey J., Crawford F., Mullan M. Induction of CD40 on human endothelial cells by Alzheimer's beta-amyloid peptides. Brain Res. Bull 1999, 50:143-148. b.
42. Town T. Alternative Abeta immunotherapy approaches for Alzheimer's disease. CNS Neurol Disord Drug Targets 2009, 8:114-127.
43. Town T., Laouar Y., Pittenger C., Mori T., Szekely C.A., Tan J., Duman R.S., Flavell R.A. Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med 2008, 14:681-687.
44. Town T., Tan J., Flavell R.A., Mullan M. T-cells in Alzheimer's disease. Neuromol. Med 2005, 7:255-264.
45. Town T., Tan J., Mullan M. CD40 signaling and Alzheimer's disease pathogenesis. Neurochem. Int 2001, 39:371-380.
46. Trabattoni D., Saresella M., Biasin M., Boasso A., Piacentini L., Ferrante P., Dong H., Maserati R., Shearer G.M., Chen L., Clerici M. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 2003, 101:2514-2520.
47. Trabattoni D., Saresella M., Pacei M., Marventano I., Mendozzi L., Rovaris M., Caputo D., Borelli M., Clerici M. Costimulatory pathways in multiple sclerosis: Distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. J. Immunol 2009, 183:4984-4993.
48. Vural P., Degirmencioglu S., Parildar-Karpuzoglu H., Dogru-Abbasoglu S., Hanagasi H.A., Karadag B., Gurvit H., Emre M., Uysal M. The combinations of TNFalpha-308 and IL-6 -174 or IL-10-1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease. Acta Neurol Scand 2009, 120:396-401.
49. Wang S., Zhu G., Chapoval A.I., Dong H., Tamada K., Ni J., Chen L. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000, 96:2808-2813.
50. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Nordberg A., Bäckman L., Albert M., Almkvist O., Arai H., Basun H., Blennow K., de Leon M., DeCarli C., Erkinjuntti T., Giacobini E., Graff C., Hardy J., Jack C., Jorm A., Ritchie K., van Duijn C., Visser P., Petersen R.C. Mild cognitive impairment--beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med 2004, 256:240-246.
51. Zhong X., Tumang J.R., Gao W., Bai C., Rothstein T.L. PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. Eur. J. Immunol 2007, 37:2405-2410.
52. Zipp F., Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci 2006, 29:518-527.